(Q68882753)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3521767%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

title

Adjuvant tamoxifen in postmenopausal breast cancer: preliminary results of a randomized trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3521767%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

1 reference

1 reference

T Delozier

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3521767%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

J P Julien

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3521767%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

P Juret

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3521767%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

C Veyret

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3521767%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

J E Couëtte

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3521767%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

Y Graic

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3521767%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

J M Ollivier

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3521767%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

E de Ranieri

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3521767%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

publication date

1 January 1986

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3521767%20AND%20SRC:MED&resulttype=core&format=json

Breast Cancer Research and Treatment

28 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3521767%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3521767%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3521767%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

page(s)

105-109

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3521767%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf01806795

28 September 2019

exact match

0 references

cites work

Treatment of primary breast cancer with chemotherapy and tamoxifen

1 reference

12 December 2020

Adjuvant endocrine therapy, cytotoxic chemotherapy, and immunotherapy in stage-II breast cancer: Five-year results

1 reference

12 December 2020

Adjuvant tamoxifen for operable carcinoma of the breast: report of clinical trial by the Christie Hospital and Holt Radium Institute

1 reference

12 December 2020

Treatment of primary breast cancer with L-PAM/5-FU and tamoxifen: An interim report

1 reference

12 December 2020

Controlled trial of tamoxifen as adjuvant agent in management of early breast cancer. Interim analysis at four years by Nolvadex Adjuvant Trial Organisation

1 reference

12 December 2020

Adjuvant chemotherapy, antiestrogen therapy and immunotherapy for stage II breast cancer: 45-month follow-up of a prospective, randomized clinical trial

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01806795

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3521767%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

1 reference